Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP788837.RAWS0J7MnnjoOCn50vS8qMUypYPE5-ltXiChTS3cxkdzk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP788837.RAWS0J7MnnjoOCn50vS8qMUypYPE5-ltXiChTS3cxkdzk130_assertion type Assertion NP788837.RAWS0J7MnnjoOCn50vS8qMUypYPE5-ltXiChTS3cxkdzk130_head.
- NP788837.RAWS0J7MnnjoOCn50vS8qMUypYPE5-ltXiChTS3cxkdzk130_assertion description "[Interest in ADAM12 has increased recently because its expression is related to tumor progression and it is a potential biomarker for breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP788837.RAWS0J7MnnjoOCn50vS8qMUypYPE5-ltXiChTS3cxkdzk130_provenance.
- NP788837.RAWS0J7MnnjoOCn50vS8qMUypYPE5-ltXiChTS3cxkdzk130_assertion evidence source_evidence_literature NP788837.RAWS0J7MnnjoOCn50vS8qMUypYPE5-ltXiChTS3cxkdzk130_provenance.
- NP788837.RAWS0J7MnnjoOCn50vS8qMUypYPE5-ltXiChTS3cxkdzk130_assertion SIO_000772 18342566 NP788837.RAWS0J7MnnjoOCn50vS8qMUypYPE5-ltXiChTS3cxkdzk130_provenance.
- NP788837.RAWS0J7MnnjoOCn50vS8qMUypYPE5-ltXiChTS3cxkdzk130_assertion wasDerivedFrom befree-20150227 NP788837.RAWS0J7MnnjoOCn50vS8qMUypYPE5-ltXiChTS3cxkdzk130_provenance.
- NP788837.RAWS0J7MnnjoOCn50vS8qMUypYPE5-ltXiChTS3cxkdzk130_assertion wasGeneratedBy ECO_0000203 NP788837.RAWS0J7MnnjoOCn50vS8qMUypYPE5-ltXiChTS3cxkdzk130_provenance.